首页 › 狼疮 › 俄克拉荷马州 › Oklahoma City
Oklahoma City OK 狼疮临床试验
8项针对 狼疮的研究正在 Oklahoma City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
招募中3 期
- Sl0044 50262, Oklahoma City
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
招募中2 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
招募中3 期
- Research Site, Oklahoma City
- Research Site, Oklahoma City
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
招募中4 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
招募中观察性研究
- Oklahoma Medical Research Foundation, Oklahoma City
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
招募中3 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- University of Oklahoma, Oklahoma City
Safety of the Herpes Zoster Subunit Vaccine in Lupus
招募中4 期
- Oklahoma Medical Research Foundation, Oklahoma City
其他城市的 狼疮试验
- New York City, NY18 项研究
- Houston, TX13 项研究
- Durham, NC12 项研究
- Miami, FL11 项研究
- Washington, DC10 项研究
- Tampa, FL9 项研究
- Philadelphia, PA9 项研究
- Clearwater, FL8 项研究
- Santa Monica, CA8 项研究
- Los Angeles, CA8 项研究
- Boston, MA8 项研究
- Chicago, IL8 项研究
Oklahoma City的其他研究
- 非小细胞肺癌28 项研究
- 卵巢癌28 项研究
- 子宫内膜癌25 项研究
- 结直肠癌22 项研究
- 前列腺癌21 项研究
- 肺癌19 项研究
- 乳腺癌17 项研究
- 转移性癌症16 项研究
- 癌症（所有类型）14 项研究
- 急性髓系白血病14 项研究
- 头颈鳞状细胞癌13 项研究
- 膀胱癌11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。